echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 40 large varieties started with tape procurement in July (with list attached)

    40 large varieties started with tape procurement in July (with list attached)

    • Last Update: 2020-06-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pharmaceutical Network June 15th,40 large varieties, julybegan to collectfrom the announcement of 40 belt procurement varieties, Shandong Province recall meeting to discuss the amount of procurement of varieties of the winning bid rules, regional selection, implementation timeIt is reported that Shandong Province for 40 varieties of collection will start in July, the specifictenderresults or in September to start implementationOn April 23, Shandong Provincial Health Insurance Bureau issued a "Notice on the Organization to Fill in part of the drug procurement plan", announcing the start of the province's belt procurementThe notice said that the selection of 40 varieties, mainly in accordance with the clinical use of large, high procurement amount, full competition principleaccording to Seber blue combing, aspirin, nitropine, metorol, fluoroguerreine, omeprazole, rebellafen, compound glycolic acid, lansorafen, left ammonia chloride equal common varieties are in the scope of this collection in Shandong - it is worth noting that in 40 varieties there are 27 injection forms, 13 oral dosage forms, injection form accounted for more than two-thirdsIn the notice, Shandong called on the province's public medical institutions (including general hospitals, Chinese medicine hospitals, specialized hospitals, maternal and child health care hospitals, nursing homes, social health service institutions, township hospitals, etc.) and military medical institutions in Lu to fill in the procurement plan, to encourage the medical insurance agreement to manage privatemedicalinstitutions voluntarily participateShandong Province requires medical institutions to refer to the actual use in 2019, to fill in the relevantdrugone year (12 months after formal implementation) procurement demand, and require medical institutions to complete online filing within three daysIt is not difficult to see that the local collection in Shandong Province, the procurement cycle is still one year   According to the relevant sources, of the 40 belt-purchased varieties, nitrobenzene flat-controlled release tablets (Bayer, Shanghai Hyundai), tacrogens (Astellas, East China) enjoy the right to bargain separately   Shandong collection of rules and breakthroughs up to now, according to Seiber blue combing, in addition to Shandong, Hunan, Hebei, Anhui, Fujian, Jiangxi, Shanxi, Yunnan, Qinghai 8 provinces have started their own provincial collection, the main positioning of hypertension, diabetes drugs, procurement of high-value antimicrobialdrugs, anti-tumor drugs, basic infusions and other varieties   It was revealed that Shandong Province, the collection, the general rules are as follows: quality level division
    the first level for the original research drug, expired patent editing drug, over-consistent evaluation of drugs, included in the generic reference preparation catalog set, China's drug list set, exported to the United Kingdom, France, The United States, Australia, Japan's drugs   Drugs in other cases are classified into the second tier In the second level there is the second prize of scientific and technological progress, product increase indications each plus 0.5 points   The winning enterprise s
    quantity the same generic name drug, each quality level can only win the bid of two   The selection conditions are set comprehensive consideration of the price reduction range, market share, coverage indicators   A level of 3 or more companies bid, according to the comprehensive score, of which the price accounted for 60%, sales 20%, coverage 20% scoring Hospitals including grass-roots communities The highest is divided into the first order of the winning variety, the second high eras must accept this price If the price is not reduced, it shall be considered as a waiver, i.e it shall be de-marked   One level of two tenders first calculated occupancy and coverage, the highest first negotiation Accept two conditions can be successful, one is determined by the average decline of three and above bids of other varieties of the same level, and the other is not higher than the price of another product platform now hanging online, not to reach the decline as a waiver   A tender must accept one of two conditions before it can either accept the average decrease of more than three products at the same level or accept the average decrease of all products   The winning bid market is divided if there are two products winning the bid in one level, the two products jointly divide the province's medical institutions 70% of the total reported volume If there is only one winning bid, the total amount of medical institutions in the province is divided 60% If there is no winning product within one level, 50% of the amount reported at that level is given to another level with the generic name variety   In the regional selection, the first winning enterprise first selected 1 city, and then alternately selected, similar to the national collection of provincial selection rules set   In general, whether it is Shandong Province, or the rest of the provinces to carry out local collection, in the large principle of belt procurement, there are different degrees of variety and rule breakthrough, such as a large number of non-consistent evaluation varieties, involving a lot of injection forms, as well as the classification of quality and so on   Some of these breakthroughs have distinctive local features, some may be important attempts and ultimately provide experience for a new round of national collection, in short, either way, it deserves the high attention of pharmaceutical companies
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.